Published in

Springer (part of Springer Nature), Annals of Surgical Oncology, 2(18), p. 559-565

DOI: 10.1245/s10434-010-1191-0

Links

Tools

Export citation

Search in Google Scholar

Serum midkine correlates with tumor progression and imatinib response in gastrointestinal stromal tumors

Journal article published in 2010 by Tamina Rawnaq, Miriam Kunkel, Kai Bachmann, Ronald Simon ORCID, Hilke Zander, Stephan Brandl, Guido Sauter, Jakob R. Izbicki, Jussuf T. Kaifi
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Introduction: A previous study identified midkine (MK) expression in primary gastrointestinal stromal tumor (GIST) as a prognostic marker. The aim of the current study was to compare serum midkine (S-MK) concentrations of GIST patients with those of healthy controls and to determine if MK can serve [for full text, please go to the a.m. URL] ; SeriesInformation ; 127. Kongress der Deutschen Gesellschaft für Chirurgie